A Study of Coti-2 for the Treatment of Advanced or Recurrent Gynecologic Malignancies

Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Endometrial Cancer;   Cervical Cancer;   Peritoneal Cancer;   Head and Neck Cancer
Intervention:   Drug: COTI2
Sponsors:   Critical Outcome Technologies Inc.;   M.D. Anderson Cancer Center;   Northwestern Memorial Hospital
Recruiting - verified February 2017

http://ift.tt/2luCk6Z